Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A.
Atassi
M Zouhair
MZ
Jankovic
Joseph
J
Dolimbek
Behzod Z
BZ
D000328:Adult; D000368:Aged; D000906:Antibodies / Q000032:analysis* / Q000097:blood / Q000494:pharmacology; D019274:Botulinum Toxins, Type A / Q000276:immunology* / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004421:Dystonia / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000276:immunology* / Q000627:therapeutic use*; D009555:Ninhydrin / Q000737:chemistry; D018709:Statistics, Nonparametric; D013542:Sweat / Q000737:chemistry / Q000276:immunology
D000906:Antibodies; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A; D009555:Ninhydrin